On the basis of the clinical findings indicating the association of TWEAK/Fn14 expression with aggressive tumor biology in CRLMs, in vitro experiments were performed to examine the effects of the TWEAK/Fn14 axis on tumor progression using two CRC cell lines, DLD‐1 and WiDr. The gene discussed is TNFRSF12A; the disease is neoplasm.